Biblio

Export 269 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is L  [Clear All Filters]
2016
K. Nunez, Kay, J., Krotow, A., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 151-63, 2016.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
N. Kandiah, Chander, R. Jude, Lin, X., Ng, A., Poh, Y. Yeong, Cheong, C. Yee, Cenina, A. Rae, and Assam, P. Nkouibert, “Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., “Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients.”, J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
J. Ku Chung, Plitman, E., Nakajima, S., M Chakravarty, M., Caravaggio, F., Takeuchi, H., Gerretsen, P., Iwata, Y., Patel, R., Mulsant, B. H., and Graff-Guerrero, A., “Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 3, pp. 743-54, 2016.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., “Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
Z. - Q. Xu, Huang, H., Chen, Y. - L., Gao, Y. - Y., Xu, J., Marshall, C., Cai, Z. - Y., and Xiao, M., “Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.”, J Alzheimers Dis, vol. 51, no. 1, pp. 179-95, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., “Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
S. Tu, Leyton, C. E., Hodges, J. R., Piguet, O., and Hornberger, M., “Divergent Longitudinal Propagation of White Matter Degradation in Logopenic and Semantic Variants of Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 49, no. 3, pp. 853-61, 2016.
T. Schütt, Helboe, L., Pedersen, L. Østergaar, Waldemar, G., Berendt, M., and Pedersen, J. Torleif, “Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.”, J Alzheimers Dis, vol. 52, no. 2, pp. 433-49, 2016.
A. M. Masoud, Bihaqi, S. W., Machan, J. T., Zawia, N. H., and Renehan, W. E., “Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1257-64, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
T. Porter, Bharadwaj, P., Groth, D., Paxman, A., Laws, S. M., Martins, R. N., and Verdile, G., “The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.”, J Alzheimers Dis, vol. 50, no. 3, pp. 895-905, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., “Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
S. Hsieh, Leyton, C. E., Caga, J., Flanagan, E., Kaizik, C., O'Connor, C. M., Kiernan, M. C., Hodges, J. R., Piguet, O., and Mioshi, E., “The Evolution of Caregiver Burden in Frontotemporal Dementia with and without Amyotrophic Lateral Sclerosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 875-85, 2016.
A. S. R. Sierksma, de Nijs, L., Hoogland, G., Vanmierlo, T., van Leeuwen, F. W., Rutten, B. P. F., Steinbusch, H. W. M., Prickaerts, J., and van den Hove, D. L. A., “Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 51, no. 3, pp. 677-82, 2016.
R. F. Palmer and Royall, D. R., “Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope.”, J Alzheimers Dis, vol. 49, no. 2, pp. 521-9, 2016.
S. Kim, Nho, K., Ramanan, V. K., Lai, D., Foroud, T. M., Lane, K., Murrell, J. R., Gao, S., Hall, K. S., Unverzagt, F. W., Baiyewu, O., Ogunniyi, A., Gureje, O., Kling, M. A., P Doraiswamy, M., Kaddurah-Daouk, R., Hendrie, H. C., and Saykin, A. J., “Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.”, J Alzheimers Dis, vol. 49, no. 4, pp. 991-1003, 2016.
J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.

Pages